Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chen Yiding & Huang Zhongyi. (2021) Differences between the quality aspects of various generic and branded docetaxel formulations. Current Medical Research and Opinion 37:8, pages 1421-1433.
Read now
Read now
Chao Hong & Jianxin Wang. (2018) Comparison of pharmaceutical quality of eight generic ganciclovir injections in China and Cymevene. Journal of Chemotherapy 30:5, pages 310-315.
Read now
Read now
Nobuaki Ochi, Hiromichi Yamane, Katsuyuki Hotta, Hiromi Fujii, Hideko Isozaki, Yoshihiro Honda, Tomoko Yamagishi, Toshio Kubo, Mitsune Tanimoto, Katsuyuki Kiura & Nagio Takigawa. (2014) Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation. Drug Design, Development and Therapy 8, pages 2401-2408.
Read now
Read now
Articles from other publishers (33)
Daniel Herchenhorn & Vinicius Freire. (2022) Access of new systemic therapies for Genito-urinary cancers in low-middle income countries. Frontiers in Urology 2.
Crossref
Crossref
Jeffrey Mathew Boby, Senthil Rajappa & Aju Mathew. (2021) Financial toxicity in cancer care in India: a systematic review. The Lancet Oncology 22:12, pages e541-e549.
Crossref
Crossref
Yanlei Kang, Yushan Zhou, Qiaoyu Wu, Ning Wang & Jianguang Zhou. (2020) Low-Content Quantitation in Entecavir Tablets Using 1064 nm Raman Spectroscopy. Journal of Spectroscopy 2020, pages 1-11.
Crossref
Crossref
Emanuela Scudellaro, Luciana Tartaglione, Fabio Varriale, Carmela Dell’Aversano & Orazio Taglialatela-Scafati. (2020) HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets. Pharmaceutics 12:4, pages 323.
Crossref
Crossref
Bianca C. Meneghini, Elaine R. Tavares, Maria C. Guido, Thauany M. Tavoni, Helio A. Stefani, Roberto Kalil-Filho & Raul C. Maranhão. (2019) Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascular Pharmacology 115, pages 46-54.
Crossref
Crossref
Purvish M Parikh & Padmaj Kulkarni. (2021) What should I Do? What should my patients Do?. Indian Journal of Medical and Paediatric Oncology 40:01, pages 3-4.
Crossref
Crossref
Chiaki Ogawa, Megumi Yatabe, Motoki Inoue, Shoko Hirose, Yasukata Ohashi, Yutaka Yachi, Shigeru Adachi & Tomoo Itoh. (2018) Comparison of Chemical Behavior of Original and Generic Docetaxel Formulations as Non-alcoholic Preparations: Discussion about Diluent Solvents for Docetaxel. YAKUGAKU ZASSHI 138:7, pages 973-984.
Crossref
Crossref
Vincent Cuzuel, Audrey Sizun, Guillaume Cognon, Isabelle Rivals, François Heulard, Didier Thiébaut & Jérôme Vial. (2018) Human odor and forensics. Optimization of a comprehensive two-dimensional gas chromatography method based on orthogonality: How not to choose between criteria. Journal of Chromatography A 1536, pages 58-66.
Crossref
Crossref
Cristiane Barata-Silva, Rachel Ann Hauser-Davis, André Luiz Oliveira da Silva & Josino Costa Moreira. (2017) Desafios ao controle da qualidade de medicamentos no Brasil. Cadernos Saúde Coletiva 25:3, pages 362-370.
Crossref
Crossref
Nour Al Faqeer & Lama Nazer. (2017) Generic and Branded Docetaxel. The Journal of Clinical Pharmacology 57:7, pages 936-936.
Crossref
Crossref
Nour Al Faqeer, Ola Mashni, Rawan Dawoud, Asma Rumman, Esraa Hanoun & Lama Nazer. (2017) Comparing the Incidence of Febrile Neutropenia Resulting in Hospital Admission Between the Branded Docetaxel and the Generic Formulations. The Journal of Clinical Pharmacology 57:2, pages 275-279.
Crossref
Crossref
Tanchanok Ratanajarusiri, Virote Sriuranpong, Piyada Sitthideatphaiboon, Nattaya Poovoravan, Chanida Vinayanuwat, Napa Parinyanitikul, Pattama Angspatt, Wilai Thawinwisan & Suebpong Tanasanvimon. (2017) A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes. Chemotherapy 62:2, pages 134-139.
Crossref
Crossref
Nicolas Guichard, Davy Guillarme, Pascal Bonnabry & Sandrine Fleury-Souverain. (2017) Antineoplastic drugs and their analysis: a state of the art review. The Analyst 142:13, pages 2273-2321.
Crossref
Crossref
Hiroko Shibata, Hiroyuki Yoshida, Ken-ichi Izutsu, Chikako Yomota, Yukihiro Goda & Haruhiro Okuda. (2016) Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan. AAPS Open 2:1.
Crossref
Crossref
Choukri Elm’hadi, Rachid Tanz, Mohamed Reda Khmamouche, Mehdi Toreis, Tarik Mahfoud, Khaoula Alaoui Slimani, Hassan Errihani & Mohammed Ichou. (2016) Toxicities of docetaxel: original drug versus generics—a comparative study about 81 cases. SpringerPlus 5:1.
Crossref
Crossref
Y Tony Yang, Sumimasa Nagai, Brian K Chen, Zaina P Qureshi, Akida A Lebby, Samuel Kessler, Peter Georgantopoulos, Dennis W Raisch, Oliver Sartor, Terhi Hermanson, Robert C Kane, William J Hrushesky, Joshua J Riente, LeAnn B Norris, Laura R Bobolts, James O Armitage & Charles L Bennett. (2016) Generic oncology drugs: are they all safe?. The Lancet Oncology 17:11, pages e493-e501.
Crossref
Crossref
Barbara MeloskyQuincy ChuRosalyn JuergensNatasha LeighlDeanna McLeodVera Hirsh. (2016) Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition. Journal of Clinical Oncology 34:14, pages 1676-1688.
Crossref
Crossref
S. Boutayeb, I. El ghissassi, S. Naceri, N. Berrada, H. Mrabti & H. Errihani. (2015) Letter to the editor. Supportive Care in Cancer 23:10, pages 2861-2861.
Crossref
Crossref
Margarita Garrido-Siles, Jose Javier Arenas-Villafranca, Elísabeth Pérez-Ruiz, M. Francisca de Linares Fernández, Begoña Tortajada, Francisco Rivas-Ruiz, Vicente Faus & Antonio Rueda. (2014) New cutaneous toxicities with generic docetaxel: are the excipients guilty?. Supportive Care in Cancer 23:7, pages 1917-1923.
Crossref
Crossref
Rodrigo González‐Ramírez, Jessica González‐Bañuelos, María de la Salud Villa, Braulio Jiménez, Pilar García‐Roca, Leticia Cruz‐Antonio, Gilberto Castañeda‐Hernández & Mara Medeiros. (2014) Bioavailability of a generic of the immunosuppressive agent mycophenolate mofetil in pediatric patients. Pediatric Transplantation 18:6, pages 568-574.
Crossref
Crossref
Atholl Johnston & David W. Holt. (2014) Substandard drugs: a potential crisis for public health. British Journal of Clinical Pharmacology 78:2, pages 218-243.
Crossref
Crossref
Éric Poirier, Christine Desbiens, Brigitte Poirier, Jean-Charles Hogue, Julie Lemieux, Catherine Doyle, Anne-France Leblond, Isabelle Côté, Guy Cantin & Louise Provencher. (2013) Comparison of Serious Adverse Events Between the Original and a Generic Docetaxel in Breast Cancer Patients. Annals of Pharmacotherapy 48:4, pages 447-455.
Crossref
Crossref
Laszlo Endrenyi & Laszlo Tothfalusi. (2012) Metrics for the Evaluation of Bioequivalence of Modified-Release Formulations. The AAPS Journal 14:4, pages 813-819.
Crossref
Crossref
Susanne Nussbaumer, Pascal Bonnabry, Jean-Luc Veuthey & Sandrine Fleury-Souverain. (2011) Analysis of anticancer drugs: A review. Talanta 85:5, pages 2265-2289.
Crossref
Crossref
Benoît Rouleau, Louise Lavoie, Jacinthe Leblanc, Simon Moretti & Chantal Collin. (2011) Reporting of Adverse Drug Reactions by Community Pharmacists: A Qualitative Study in Quebec. Drug Information Journal 45:5, pages 627-639.
Crossref
Crossref
Peter M. Kondra, Laszlo Endrenyi & Laszlo Tothfalusi. (2011) The Need for Additional Metrics to Assess Therapeutic Equivalence of Some Multiphasic Modified-Release Products. Clinical Therapeutics 33:9, pages 1214-1219.
Crossref
Crossref
Thomas Dutriez, Julie Borras, Marion Courtiade, Didier Thiébaut, Hugues Dulot, Fabrice Bertoncini & Marie-Claire Hennion. (2011) Challenge in the speciation of nitrogen-containing compounds in heavy petroleum fractions by high temperature comprehensive two-dimensional gas chromatography. Journal of Chromatography A 1218:21, pages 3190-3199.
Crossref
Crossref
Laure Mahé, Thomas Dutriez, Marion Courtiade, Didier Thiébaut, Hugues Dulot & Fabrice Bertoncini. (2011) Global approach for the selection of high temperature comprehensive two-dimensional gas chromatography experimental conditions and quantitative analysis in regards to sulfur-containing compounds in heavy petroleum cuts. Journal of Chromatography A 1218:3, pages 534-544.
Crossref
Crossref
Atholl Johnston, Panagiotis Stafylas & George S. Stergiou. (2010) Effectiveness, safety and cost of drug substitution in hypertension. British Journal of Clinical Pharmacology 70:3, pages 320-334.
Crossref
Crossref
Depalmo Galli Angeli & Carlo Trezza. (2009) Quality and Stability of Ramipril Generics/Copies versus Reference Ramipril (Tritace®). Clinical Drug Investigation 29:10, pages 667-676.
Crossref
Crossref
Thomas Dutriez, Marion Courtiade, Didier Thiébaut, Hugues Dulot, Fabrice Bertoncini, Jérôme Vial & Marie-Claire Hennion. (2009) High-temperature two-dimensional gas chromatography of hydrocarbons up to nC60 for analysis of vacuum gas oils. Journal of Chromatography A 1216:14, pages 2905-2912.
Crossref
Crossref
Hyun-Jo Kim. (2009) Parenteral Docetaxel Emulsion System and Its Stability. Journal of Korean Pharmaceutical Sciences 39:1, pages 13-18.
Crossref
Crossref
Ji-Sook Lee, Kyoung-Ja Woo & He-Sson Chung. (2009) Preparation and Cellular Uptake of Hydrophobic Quantum Dots Encapsulated in Poly-L-Lactic Acid Film. Journal of Korean Pharmaceutical Sciences 39:1, pages 1-6.
Crossref
Crossref